AAAAAA
Results: 1-25/42
Authors:
Cleland, JGF
Daubert, JC
Erdmann, E
Freemantle, N
Gras, D
Kappenberger, L
Klein, W
Tavazzi, L
Citation: Jgf. Cleland et al., The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points, EUR J HE FA, 3(4), 2001, pp. 481-489
Authors:
Zermansky, AG
Petty, DR
Raynor, DK
Freemantle, N
Vail, A
Lowe, CJ
Citation: Ag. Zermansky et al., Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice, BR MED J, 323(7325), 2001, pp. 1340-1343
Authors:
Mason, J
Freemantle, N
Browning, G
Citation: J. Mason et al., Impact of Effective Health Care bulletin on treatment of persistent glue ear in children: time series analysis, BR MED J, 323(7321), 2001, pp. 1096-1097
Authors:
Freemantle, N
Wood, J
Citation: N. Freemantle et J. Wood, Evaluating guidelines across primary care-secondary care interface - Methodological weaknesses and poor reporting undermine authors' conclusions, BR MED J, 323(7316), 2001, pp. 808-808
Authors:
Freemantle, N
Citation: N. Freemantle, Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?, BR MED J, 322(7292), 2001, pp. 989-991
Authors:
Geddes, J
Harrison, P
Freemantle, N
Bebbington, P
Citation: J. Geddes et al., Atypical antipsychotics in the treatment of schizophrenia - Reply, BR MED J, 322(7291), 2001, pp. 927-928
Authors:
Petty, DR
Zermansky, AG
Raynor, DK
Vail, A
Lowe, CJ
Freemantle, N
Buttress, AD
Citation: Dr. Petty et al., "No thank you": Why elderly patients declined to participate in a researchstudy, PHARM WORLD, 23(1), 2001, pp. 22-27
Authors:
Freemantle, N
Behmane, D
de Joncheere, K
Citation: N. Freemantle et al., Pricing and reimbursement of pharmaceuticals in the Baltic States, LANCET, 358(9278), 2001, pp. 260-260
Authors:
Freemantle, N
Citation: N. Freemantle, Cost-effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) - what makes a NSAID good value for money?, RHEUMATOLOG, 39(3), 2000, pp. 232-234
Authors:
Houghton, T
Freemantle, N
Cleland, JGF
Citation: T. Houghton et al., Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials, EUR J HE FA, 2(3), 2000, pp. 333-340
Authors:
Cleland, JGF
Swedberg, K
Cohen-Solal, A
Cosin-Aguilar, J
Dietz, R
Follath, F
Gavazzi, A
Hobbs, R
Korewicki, J
Madeira, HC
Preda, I
van Gilst, WH
Widimsky, J
Mareev, V
Mason, J
Freemantle, N
Eastaugh, J
Citation: Jgf. Cleland et al., A survey on the quality of care among patients with heart failure in Europe, EUR J HE FA, 2(2), 2000, pp. 123-132
Authors:
Freemantle, N
Mason, J
Citation: N. Freemantle et J. Mason, The importance of achieving additional drug benefits at a reasonable cost - A review of the fluoxetine years, PHARMACOECO, 17(4), 2000, pp. 319-324
Authors:
Eccles, M
Mason, J
Freemantle, N
Citation: M. Eccles et al., Developing valid cost effectiveness guidelines: a methodological report from the North of England evidence based guideline development project, QUAL HEAL C, 9(2), 2000, pp. 127-132
Authors:
Mason, J
Freemantle, N
Eccles, M
Citation: J. Mason et al., Fatal toxicity associated with antidepressant use in primary care, BR J GEN PR, 50(454), 2000, pp. 366-370
Authors:
Freemantle, N
Citation: N. Freemantle, StatsDirect - Statistical software for medical research in the 21st century, BR MED J, 321(7275), 2000, pp. 1536-1536
Authors:
Geddes, J
Freemantle, N
Harrison, P
Bebbington, P
Citation: J. Geddes et al., Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis, BR MED J, 321(7273), 2000, pp. 1371-1376
Authors:
Mason, J
Young, P
Freemantle, N
Hobbs, R
Citation: J. Mason et al., Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction, BR MED J, 321(7269), 2000, pp. 1113-1116
Authors:
Freemantle, N
Citation: N. Freemantle, Valuing the effects of sildenafil in erectile dysfunction - Strong assumptions are required to generate a QALY value, BR MED J, 320(7243), 2000, pp. 1156-1157
Authors:
Freemantle, N
Johnson, R
Dennis, J
Kennedy, A
Marchment, M
Citation: N. Freemantle et al., Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice, BR J CL PH, 49(2), 2000, pp. 174-179
Authors:
Freemantle, N
Citation: N. Freemantle, Implementation strategies, FAM PRACT, 17, 2000, pp. S7-S10
Authors:
Freemantle, N
Anderson, IM
Young, P
Citation: N. Freemantle et al., Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs - Meta-regression analysis, BR J PSYCHI, 177, 2000, pp. 292-302
Authors:
Cleland, JGF
Tendera, M
Adamus, J
Freemantle, N
Gray, CS
Lye, M
O'Mahony, D
Polonski, L
Taylor, J
Citation: Jgf. Cleland et al., Perindopril for elderly people with chronic heart failure: the PEP-CHF study, EUR J HE FA, 1(3), 1999, pp. 211-217
Authors:
Freemantle, N
Citation: N. Freemantle, Dictionary of evidence-based medicine, HEALTH ECON, 8(2), 1999, pp. 185-185
Authors:
Freemantle, N
Mason, J
Citation: N. Freemantle et J. Mason, Paper has errors and omissions - Reply, BR MED J, 319(7215), 1999, pp. 1006-1007
Authors:
Freemantle, N
Mason, J
Citation: N. Freemantle et J. Mason, Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate (vol 318, pg 1480, 1999), BR MED J, 319(7203), 1999, pp. 185-185